Experience with Reviewing Bayesian Medical Device Trials

The purpose of this paper is to present a statistical reviewer's perspective on some technical aspects of reviewing Bayesian medical device trials submitted to the Food and Drug Administration. The discussion reflects the experiences of the authors and should not be misconstrued as official guidance by the FDA. A variety of applications are described, reflecting our experience with therapeutic and diagnostic devices. In addition to Bayesian analysis of trials, Bayesian trial design and Bayesian monitoring are discussed. Analyses were implemented in WinBUGS (http://www.mrc-bsu.cam.ac.uk/bugs/winbugs/contents.shtml), with the code provided.

[1]  Tie-Hua Ng.  Issues of Simultaneous Tests for Noninferiority and Superiority , 2003, Journal of biopharmaceutical statistics.

[2]  Colin B. Begg,et al.  On inferences from Wei's biased coin design for clinical trials , 1990 .

[3]  R. F. Wagner,et al.  The problem of ROC analysis without truth: the EM algorithm and the information matrix , 2000, Medical Imaging.

[4]  A. Gelman.  Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper) , 2004 .

[5]  Lyle D. Broemeling,et al.  Bayesian Biostatistics and Diagnostic Medicine , 2007 .

[6]  Bradley P. Carlin,et al.  BAYES AND EMPIRICAL BAYES METHODS FOR DATA ANALYSIS , 1996, Stat. Comput..

[7]  D. Malec,et al.  A closer look at combining data among a small number of binomial experiments , 2001, Statistics in medicine.

[8]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[9]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[10]  Matthew A. Kupinski,et al.  Objective Comparison of Quantitative Imaging Modalities Without the Use of a Gold Standard , 2001, IPMI.

[11]  R. Simon,et al.  Bayesian subset analysis. , 1991, Biometrics.

[12]  B. Turnbull,et al.  Group Sequential Methods with Applications to Clinical Trials , 1999 .

[13]  G. Campbell,et al.  Interpretation of Subgroup Analyses in Medical Device Clinical Trials* , 1998 .

[14]  Fei Wang,et al.  A simulation-based approach to Bayesian sample size determination for performance under a given model and for separating models , 2002 .

[15]  G. Shaddick,et al.  Use of Stone's method in studies of disease risk around point sources of environmental pollution. , 1996, Statistics in medicine.

[16]  R Simon,et al.  Bayesian Design and Analysis of Active Control Clinical Trials , 1999, Biometrics.

[17]  S J Pocock,et al.  The combination of randomized and historical controls in clinical trials. , 1976, Journal of chronic diseases.

[18]  Xiao-Li Meng,et al.  POSTERIOR PREDICTIVE ASSESSMENT OF MODEL FITNESS VIA REALIZED DISCREPANCIES , 1996 .

[19]  D. Berry.  Bayesian Statistics and the Efficiency and Ethics of Clinical Trials , 2004 .

[20]  T. Louis,et al.  Bayes and Empirical Bayes Methods for Data Analysis. , 1997 .

[21]  L. Joseph,et al.  Bayesian Approaches to Modeling the Conditional Dependence Between Multiple Diagnostic Tests , 2001, Biometrics.

[22]  T. Morikawa,et al.  A useful testing strategy in phase III trials: combined test of superiority and test of equivalence. , 1995, Journal of biopharmaceutical statistics.

[23]  William DuMouchel,et al.  Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System , 1999 .

[24]  A James O'Malley,et al.  SAMPLE SIZE CALCULATION FOR A HISTORICALLY CONTROLLED CLINICAL TRIAL WITH ADJUSTMENT FOR COVARIATES , 2002, Journal of biopharmaceutical statistics.

[25]  John K Kruschke,et al.  Bayesian data analysis. , 2010, Wiley interdisciplinary reviews. Cognitive science.

[26]  R. F. Wagner,et al.  Components-of-variance models and multiple-bootstrap experiments: an alternative method for random-effects, receiver operating characteristic analysis. , 2000, Academic radiology.

[27]  R A Greenes,et al.  Assessment of Diagnostic Technologies: Methodology for Unbiased Estimation from Samples of Selectively Verified Patients , 1985, Investigative radiology.

[28]  M Gent,et al.  An alternative to the use of two-sided tests in clinical trials. , 1996, Statistics in medicine.

[29]  Wesley O. Johnson,et al.  Correlation‐adjusted estimation of sensitivity and specificity of two diagnostic tests , 2003 .

[30]  A. Gelfand,et al.  Efficient parametrisations for normal linear mixed models , 1995 .

[31]  Hamid Pezeshk,et al.  Bayesian techniques for sample size determination in clinical trials: a short review , 2003, Statistical methods in medical research.

[32]  Paul C. Lambert.  Comment on article by Browne and Draper , 2006 .

[33]  R. Simon,et al.  Bayesian subset analysis in a colorectal cancer clinical trial. , 1992, Statistics in medicine.

[34]  Huiman X Barnhart,et al.  A global sensitivity analysis of performance of a medical diagnostic test when verification bias is present , 2003, Statistics in medicine.

[35]  P. Albert,et al.  A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard , 2004, Biometrics.

[36]  Eric Clarkson,et al.  Estimation in medical imaging without a gold standard. , 2002, Academic radiology.

[37]  J. Ibrahim,et al.  Power prior distributions for regression models , 2000 .

[38]  Timothy D Johnson,et al.  A Bayesian hierarchical approach to multirater correlated ROC analysis. , 2006, Statistics in medicine.

[39]  B. Craig,et al.  Estimating disease prevalence in the absence of a gold standard , 2002, Statistics in medicine.

[40]  D J Spiegelhalter,et al.  Flexible random‐effects models using Bayesian semi‐parametric models: applications to institutional comparisons , 2007, Statistics in medicine.